Impaired renal endothelial nitric oxide synthase and reticulocyte production as modulators of hypertension induced by recombinant human erythropoietin in the rat

INTRODUCTION AND AIMS: Hypertension is a common side effect of recombinant human erythropoietin (rHuEPO) therapy; however, the exact pathways remain to be elucidated. The discovery of non-hematopoietic actions of rHuEPO increased the number of patients that could putatively benefit from this therapy...

Full description

Bibliographic Details
Main Author: Ribeiro, Sandra (author)
Other Authors: Garrido, Patrícia (author), Fernandes, João (author), Vala, Helena (author), Rocha-Pereira, Petronila (author), Costa, Elísio (author), Belo, Luís (author), Reis, Flávio (author), Santos-Silva, Alice (author)
Format: conferenceObject
Language:eng
Published: 2016
Subjects:
Hypertension
recombinant human erythropoietin (rHuEPO) therapy
renal lesions
renal function and damage
Online Access:http://hdl.handle.net/10400.19/3197
Country:Portugal
Oai:oai:repositorio.ipv.pt:10400.19/3197

Internet

http://hdl.handle.net/10400.19/3197

Similar Items